News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Justin Taylor: XPO1 Can Be Targeted in TP53-Mutated Myeloid Malignancies
Justin Taylor/X
Aug 1, 2025, 10:25

Justin Taylor: XPO1 Can Be Targeted in TP53-Mutated Myeloid Malignancies

Justin Taylor, Assistant Professor at the UM Sylvester Comprehensive Cancer Center, shared a post on X about recent paper he and colleagues co-authored:

“Super excited to see our collaboration with Eric Padron online in Blood!

Congrats to first author Traci Kruer!

XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid Malignancies.”

Title: XPO1 Drives Resistance to Eprenetapopt and Azacitidine and Can Be Targeted in TP53-Mutated Myeloid Malignancies

Authors: Traci L Kruer, Ariel Quintana-Gonzalez, Hannah L Newman, Meghan C. Ferrall-Fairbanks, Ling Zhang, Amy F McLemore, Surendra Neupane, Qin Yang, Nana Adjoa Ben-Crentsil, Maria E. Balasis, Christopher T Letson, Rami S Komrokji, Sana Chaudhry, Tulasigeri M Totiger, Joshua A Traina, Maria E Figueroa, Christopher B Ryder, Thomas Cluzeau, Justin Taylor, David A Sallman, Eric Padron

Read The Full Article at Blood.

Justin Taylor: XPO1 Can Be Targeted in TP53-Mutated Myeloid Malignancies

More posts featuring Justin Taylor on OncoDaily.

Amy F McLemore Ariel Quintana-Gonzalez cancer Christopher B Ryder Christopher T Letson David A. Sallman Eric Padron Hannah L Newman Joshua A Traina Justin Taylor Ling Zhang Maria E Balasis Maria E Figueroa Meghan C Ferrall-Fairbanks Nana Adjoa Ben-Crentsil OncoDaily Oncology Qin Yang Rami S Komrokji Sana Chaudhry Surendra Neupane Thomas Cluzeau Traci L Kruer Tulasigeri M. Totiger
Special Coverage
Voices
Aug 21, 2025, 13:39
Boston City Councilor Visited Dana-Farber to Learn About EQUAL Study
Voices
Aug 21, 2025, 13:35
David Skorton: $2 Billion Loss - NIH Funding Crisis Hits Clinical Trials
Insight
Aug 21, 2025, 13:21
Harpreet Singh: FDA’s New Draft Guidance on Radiopharmaceutical Dosing Is Here
Voices
Aug 21, 2025, 13:19
Miriam Mutebi: Why We Need to Expand Research in Palliative and Supportive Care
Insight
Aug 21, 2025, 13:16
Javier Martin-Broto: Collaborative Study Supports Mifamurtide Use in Osteosarcoma Treatment
Voices
Aug 21, 2025, 12:57
How Cancer-Induced Nerve Injury Contributes to Immunotherapy Resistance - MD Anderson Cancer Center
Voices
Aug 21, 2025, 12:34
Nirmala Bhoo Pathy: First-Ever Workshop on Patient and Financial Navigation
Immune Oncology
Aug 21, 2025, 12:34
PPP2R1A Mutations as a Biomarker in Immunotherapy: New Insights from Ovarian Clear Cell Carcinoma
Insight
Aug 21, 2025, 12:31
Alisher Kahharov: Uzbekistan's First National Breast Cancer Guideline - A Collaborative Effort with WHO and Georgian Experts
Radiotherapy
Aug 21, 2025, 12:31
New RT Paper Alert: Novel NOVEMBER Trial Puts 9-Day Breast Cancer Radiation Schedule to the Test
Opinion
Aug 21, 2025, 12:03
UICC Enhances Cancer Care with Nutrition and Psycho-Oncology Support
Voices
Aug 21, 2025, 11:40
FDA has Granted Full Market Approval for Papzimeos - NIH